Mural Oncology plc Board of Directors

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

Ms. Caroline J. Loew Ph.D.

Ms. Caroline J. Loew Ph.D.

President, CEO & Director

Mr. Adam D. Cutler B.A.

Mr. Adam D. Cutler B.A.

CFO, Principal Financial Officer & Principal Accounting Officer

Mr. Justin Levine

Mr. Justin Levine

Head of Human Resources & VP of Human Resources

Comments